Target RWE Research Presented at DDW 2021 Shows High Rates of Biologic Combination Therapy and Previous Biologic Exposure in IBD Population ...Middle East

DURHAM, N.C., May 23, 2021 /PRNewswire/ -- Research presented today at Digestive Disease Week (DDW) 2021 evaluated the prevalence and predictors of immunomodulator use as concomitant therapy with two commonly prescribed biologics, vedolizumab (Entyvio) or ustekinumab (Stelara), in...

Hence then, the article about target rwe research presented at ddw 2021 shows high rates of biologic combination therapy and previous biologic exposure in ibd population was published today ( Sunday 23/05/2021 - 07:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Target RWE Research Presented at DDW 2021 Shows High Rates of Biologic Combination Therapy and Previous Biologic Exposure in IBD Population )

Also on site :

• Maria Shriver Sends a Clear Message About America's Future: 'No More Excuses'
• Aldi's 3-Piece Vintage-Inspired Apothecary Jar Set Will Elevate Your Bathroom Organization Beautifully
• Russia-Ukraine war: List of key events, day 1,433